Mid Atlantic Financial Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$851K Sell
17,726
-816
-4% -$39.4K 0.06% 296
2021
Q2
$777K Sell
18,542
-1,418
-7% -$55K 0.05% 325
2021
Q1
$673K Buy
19,960
+88
+0.4% +$3.13K 0.05% 358
2020
Q4
$694K Sell
19,872
-500
-2% -$17.3K 0.05% 316
2020
Q3
$692K Sell
20,372
-3,404
-14% -$113K 0.06% 282
2020
Q2
$778K Buy
23,776
+48
+0.2% +$1.53K 0.07% 234
2020
Q1
$714K Buy
23,728
+3,652
+18% +$109K 0.08% 232
2019
Q4
$581K Sell
20,076
-400
-2% -$11.1K 0.05% 348
2019
Q3
$529K Sell
20,476
-390
-2% -$9.86K 0.06% 339
2019
Q2
$532K Buy
20,866
+104
+0.5% +$2.57K 0.06% 351
2019
Q1
$543K Sell
20,762
-282
-1% -$6.93K 0.06% 342
2018
Q4
$485K Buy
+21,044
New +$468K 0.06% 342

Other funds holding NVO

Mid Atlantic Financial Management's NVO Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Novo Nordisk (NVO) stake by 4.4% in Q3 2021, selling an estimated $39.4K and leaving 17,726 shares worth $851K. The position accounts for 0.06% of the portfolio, ranked #296.

Mid Atlantic Financial Management first reported a position in NVO in Q4 2018 and has held it in 12 quarters since. 805 funds tracked by Wall St. Rank hold NVO as of Q3 2021.

  • Mid Atlantic Financial Management held 17,726 shares of Novo Nordisk worth $851K as of Q3 2021.
  • Mid Atlantic Financial Management sold 816 Novo Nordisk shares in Q3 2021, an estimated $39.4K.
  • Novo Nordisk made up 0.06% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #296 holding.
  • Mid Atlantic Financial Management first reported a position in Novo Nordisk in Q4 2018 and has held it in 12 quarters since.
  • 805 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.